Next Article in Journal
Cost-Effectiveness of Vaccination of Older Adults with an MF59®-Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden
Next Article in Special Issue
Determinants of Human Papillomavirus Vaccine Acceptance among Caregivers in Nigeria: A Fogg Behavior Model-Based Approach
Previous Article in Journal
Plant-Produced Anti-Zika Virus Monoclonal Antibody Glycovariant Exhibits Abrogated Antibody-Dependent Enhancement of Infection
Previous Article in Special Issue
Low Uptake of the Second Dose of Human Papillomavirus Vaccine in Dar es Salaam, Tanzania
 
 
Article

Article Versions Notes

Vaccines 2023, 11(4), 754; https://doi.org/10.3390/vaccines11040754
Action Date Notes Link
article xml file uploaded 29 March 2023 09:39 CEST Original file -
article xml uploaded. 29 March 2023 09:39 CEST Update -
article pdf uploaded. 29 March 2023 09:39 CEST Version of Record -
article html file updated 29 March 2023 09:40 CEST Original file -
article xml file uploaded 29 March 2023 10:31 CEST Update -
article xml uploaded. 29 March 2023 10:31 CEST Update https://www.mdpi.com/2076-393X/11/4/754/xml
article pdf uploaded. 29 March 2023 10:31 CEST Updated version of record https://www.mdpi.com/2076-393X/11/4/754/pdf
article html file updated 29 March 2023 10:32 CEST Update -
article html file updated 6 April 2023 23:25 CEST Update https://www.mdpi.com/2076-393X/11/4/754/html
Back to TopTop